Identification of chemically modified peptide from poly(D,L-lactide-co-glycolide) microspheres under in vitro release conditions
- PMID: 15198545
- PMCID: PMC2750643
- DOI: 10.1208/pt040450
Identification of chemically modified peptide from poly(D,L-lactide-co-glycolide) microspheres under in vitro release conditions
Abstract
The purpose of this research was to study the chemical reactivity of a somatostatin analogue, octreotide acetate, formulated in microspheres with polymers of varying molecular weight and co-monomer ratio under in vitro testing conditions. Poly(D,L-lactide-co-glycolide) (PLGA) and poly(D,L-lactide) (PLA) microspheres were prepared by a solvent extraction/evaporation method. The microspheres were characterized for drug load, impurity content, and particle size. Further, the microspheres were subjected to in vitro release testing in acetate buffer (pH 4.0) and phosphate buffered saline (PBS) (pH 7.2). In acetate buffer, 3 microsphere batches composed of low molecular weight PLGA 50:50, PLGA 85:15, and PLA polymers (< or =10 kDa) showed 100% release with minimal impurity formation (<10%). The high molecular weight PLGA 50:50 microspheres (28 kDa) displayed only 70% cumulative release in acetate buffer with significant impurity formation (approximately 24%). In PBS (pH 7.4), on the other hand, only 50% release was observed with the same low molecular weight batches (PLGA 50:50, PLGA 85:15, and PLA) with higher percentages of hydrophobic impurity formation (ie, 40%, 26%, and 10%, respectively). In addition, in PBS, the high molecular weight PLGA 50:50 microspheres showed only 20% drug release with ~66% mean impurity content. The chemically modified peptide impurities inside microspheres were structurally confirmed through Fourier transform-mass spectrometry (FT-MS) and liquid chromatography/mass spectrometry (LC-MS/MS) analyses after extraction procedures. The adduct compounds were identified as covalently modified conjugates of octreotide with lactic and glycolic acid monomers within polymeric microspheres. The data suggest that due to steric hindrance factors, polymers with greater lactide content were less amenable to the formation of adduct impurities compared with PLGA 50:50 copolymers.
Similar articles
-
Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.Eur J Pharm Biopharm. 2008 Feb;68(2):214-23. doi: 10.1016/j.ejpb.2007.06.008. Epub 2007 Jun 15. Eur J Pharm Biopharm. 2008. PMID: 17651954
-
Impurity formation studies with peptide-loaded polymeric microspheres Part I. In vivo evaluation.Int J Pharm. 2005 Jun 13;297(1-2):50-61. doi: 10.1016/j.ijpharm.2005.02.035. Int J Pharm. 2005. PMID: 15893894
-
Impurity formation studies with peptide-loaded polymeric microspheres Part II. In vitro evaluation.Int J Pharm. 2005 Jun 13;297(1-2):62-72. doi: 10.1016/j.ijpharm.2005.02.034. Int J Pharm. 2005. PMID: 15885939
-
The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices.Biomaterials. 2000 Dec;21(23):2475-90. doi: 10.1016/s0142-9612(00)00115-0. Biomaterials. 2000. PMID: 11055295 Review.
-
Drug microencapsulation by PLA/PLGA coacervation in the light of thermodynamics. 1. Overview and theoretical considerations.J Pharm Sci. 1998 Mar;87(3):259-68. doi: 10.1021/js970047r. J Pharm Sci. 1998. PMID: 9523976 Review.
Cited by
-
Recent Progress in Drug Release Testing Methods of Biopolymeric Particulate System.Pharmaceutics. 2021 Aug 23;13(8):1313. doi: 10.3390/pharmaceutics13081313. Pharmaceutics. 2021. PMID: 34452274 Free PMC article. Review.
-
PEGylation of octreotide: I. Separation of positional isomers and stability against acylation by poly(D,L-lactide-co-glycolide).Pharm Res. 2005 May;22(5):736-42. doi: 10.1007/s11095-005-2589-4. Epub 2005 May 17. Pharm Res. 2005. PMID: 15906168
-
A new class of inhibitors of peptide sorption and acylation in PLGA.J Control Release. 2009 Aug 4;137(3):179-84. doi: 10.1016/j.jconrel.2009.03.006. Epub 2009 Mar 24. J Control Release. 2009. PMID: 19318114 Free PMC article.
-
Minimizing acylation of peptides in PLGA microspheres.J Control Release. 2012 Aug 20;162(1):119-26. doi: 10.1016/j.jconrel.2012.04.022. Epub 2012 Apr 21. J Control Release. 2012. PMID: 22546683 Free PMC article.
-
Preparation and stability of poly(ethylene glycol) (PEG)ylated octreotide for application to microsphere delivery.AAPS PharmSciTech. 2003 Dec 31;4(4):E72. doi: 10.1208/pt040472. AAPS PharmSciTech. 2003. PMID: 15198567 Free PMC article.
References
-
- Hunter SJ, Shaw JA, Lee KO, Wood PJ, Atkinson AB, Bevan JS. Comparison of monthly intramuscular injections of Sandostatin LAR with multiple subcutaneous injections of octreotide in the treatment of acromegaly: effects on growth hormone and other markers of growth hormone secretion. Clin Endocrinol (Oxf). 1999;50(2):245–251. doi: 10.1046/j.1365-2265.1999.00668.x. - DOI - PubMed
-
- Tsai T, Mehta RC, DeLuca PP. Adsorption of peptides to poly(D,L-lactide-co-glycolide). 1. Effect of physical factors on the adsorption. Int J Pharm. 1996;127:31–42. doi: 10.1016/0378-5173(95)04111-7. - DOI
-
- Tsai T, Mehta RC, DeLuca PP. Adsorption of peptides to poly(D,L-lactide-co-glycolide). 2. Effect of solution properties on the adsorption. Int J Pharm. 1996;127:43–52. doi: 10.1016/0378-5173(95)04112-5. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources